Why South Africa 2030 Targets How It Helps Partners Device

Point-of-care cervical screening

Making
near-care
a reality

TruScreen delivers an AI-enabled cervical assessment in minutes — helping providers identify women who need further care before they leave the room. No laboratory. No sample transport. No waiting weeks for a result.

TruScreen handheld device
Supporting South Africa's path to the WHO Cervical Cancer Elimination targets

The gap this closes

Same distance. Wildly different wait.

The usual pathway 0 days
Sample collectedTransportLab queueProcessingReport issuedPatient returns
The TruScreen pathway 0 min
Visit beginsAssessmentResult given

Every day between a sample and a result is a day a woman can disengage from care. Loss to follow-up — not lack of screening alone — is one of the largest drivers of preventable cervical cancer deaths.

Why South Africa needs a different approach

Cervical cancer still takes too many women too early — even where vaccination and screening are improving.

TruScreen brings the assessment to where a woman already is, and returns a result before she leaves.

  • Long travel distances01
  • Delayed laboratory results02
  • Missed follow-up appointments03
  • Limited specialist access04
  • Urban–rural screening inequality05

Key benefits

What changes at the point of care.

01

Real-time results

The screening outcome is available during the patient visit — not days or weeks later.

02

No laboratory required

Built for primary clinics, mobile screening units, and rural healthcare programmes.

03

AI-enabled assessment

Optical and electrical measurements interpreted by algorithms trained on extensive clinical data.

04

Wider reach

Screen more women closer to where they live, including areas labs can't easily serve.

05

Less loss to follow-up

An immediate result removes the days-long gap where women disengage from care.

06

Public health leverage

More coverage and earlier detection, with less pressure on an already stretched system.

WHO 2030 cervical cancer elimination strategy

Can South Africa reach 90-70-90?

90%

HPV vaccination coverage

70%

Screened with a high-performance test

← where TruScreen fits

90%

Precancer and invasive disease treated

A country that reaches all three targets by 2030 moves from managing cervical cancer to eliminating it as a public health problem. Coverage is the target TruScreen is built to move.

The challenge

A burden that doesn't fall evenly.

Cervical cancer disproportionately affects women where screening access is least consistent — amplified by unequal healthcare access, rural distance, limited infrastructure, and constrained follow-up capacity.

Laboratory dependency

Sample → transport → process → report

Each handoff is a place for delay and operational complexity to enter the pathway.

Loss to follow-up

The wait is where patients disappear

When a result takes days or weeks, women may not return for treatment or further assessment — one of the biggest barriers in cervical cancer prevention.

Rural access

Distance lowers participation

Communities far from labs and specialists see lower screening uptake and later intervention.

How TruScreen helps

Built to remove the operational barriers, not add new ones.

01

Same-day screening

Women receive a result during the appointment itself.

02

No sample transport

Assessment happens at the point of care — nothing to courier, nothing to lose in transit.

03

No laboratory requirement

Deployable wherever care already happens.
ClinicsCommunity health centresMobile unitsRural programmes
04

Fast assessment

A screening examination typically takes only a few minutes.

05

Scalable deployment

The same device and workflow scale from urban hospitals to mobile rural outreach.

Public health programmes

Already part of national screening initiatives.

Incorporated into public health screening efforts focused on expanding access and reducing barriers to care.

VietnamZimbabweChinaIndiaIndonesiaUzbekistan VietnamZimbabweChinaIndiaIndonesiaUzbekistan

Designed for South African healthcare

Built to plug into the system you already run.

Public sector

Government & provincial care

  • Provincial health departments
  • District hospitals
  • Primary healthcare clinics

Private sector

Hospitals & specialist care

  • Hospital groups
  • Women's health clinics
  • Gynaecology practices

NGOs & programmes

Outreach & community care

  • Community screening initiatives
  • Mobile healthcare services
  • Women's health programmes

Laboratory partnership

Working with laboratories, not against them.

TruScreen helps laboratories by

  • Expanding overall screening coverage
  • Identifying higher-risk patients earlier
  • Reducing delays in the wider system
  • Strengthening referral pathways

Laboratories remain essential for

  • HPV testing
  • Histopathology
  • Confirmatory diagnosis
  • Complex case management

TruScreen isn't built to replace laboratory testing. It's built to widen the front door of the screening system — so more women reach it in the first place.

The cost of waiting

A woman screened today may avoid invasive cancer tomorrow.

Every missed screening

raises late-diagnosis risk

Earlier intervention

lowers treatment cost

Fewer delays

less burden on the system

Let's talk

Let's eliminate cervical
cancer together.

Provincial Health Department Hospital Group Laboratory Network Women's Health NGO Corporate Health Programme